Navigation Links
Hologic Announces Third Quarter Fiscal 2008 Operating Results
Date:7/30/2008

due to an increase in the number of mini C-arms sold and, to a lesser extent, an increase in the number of bone densitometry systems sold during the quarter. The operating income for this business segment in the third quarter of fiscal 2008 increased to $3.2 million compared to operating income of $188,000 in the third quarter of fiscal 2007. Skeletal Health costs and expenses in the third quarters of fiscal 2008 and 2007 included $0.4 million and $0.3 million, respectively, of stock-based compensation.

Third Wave Technologies:

On July 24, 2008, Hologic completed the acquisition of Third Wave for approximately $600 million. In connection with this acquisition the Company entered into amended credit agreement providing $400 million of senior secured tranche A and $140 million of senior secured tranche B term loans.

Tomosynthesis Update:

Earlier today we received a letter from the FDA requesting additional information in connection with our PMA application for our new 3-D full field digital mammography system (Tomosynthesis). We are confident we have the necessary data, will begin compiling the information, and expect to respond shortly. Considering the response time and the scheduling of a panel review we are now expecting approval to market this product in the U.S. in the first calendar quarter of 2009. Our launch of the product outside the U.S. remains on track for shipments in our December 2008 quarter.

Financial Guidance:

-- Fourth quarter fiscal 2008 revenues are expected to increase to $438 - $439 million, driven by an increase of Selenias sold of 434 and the inclusion of Third Wave. This is expected to result in total fiscal 2008 revenues of approximately $1.67 billion.

-- Total Selenias expected to be sold are now 1,665 in fiscal 2008, up from prior guidance of 1,655.

-- The inclusion of Third Wave for just over two months is expected to be dilutive to Hologic's Q4 and fiscal 2008 results. In connection
'/>"/>

SOURCE Hologic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Psychological downside to strike action
2. Psychological and Social Issues Associated With Tooth Loss
3. Psychological and social issues associated with tooth loss
4. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
5. Hologic to Present at the Jefferies 2nd Annual Healthcare Conference
6. Hologic to Acquire Third Wave Technologies
7. Metformin increases pathologic complete response rates in breast cancer patients with diabetes
8. Hologic to Present at NASDAQs 21st Investor Program in London
9. Hologic Announces Organizational Change
10. Can pathological techniques help identify primary colorectal signet ring cell carcinoma?
11. Electric shocks can cause neurologic and neuropsychological symptoms

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...SNewswire/--Newpeer-revieweddatafindingthatfewerth...hchronichepatitisCvirushavereceivedanti-viralthera...dstomoveurgentlyonbipartisanlegislationtosupportne...rts,the NationalViralHepatitisRoundtable(NVHR) sai...action,millionsofAmericansinfectedwithchronichepat...
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ing from women,s hair loss for almost ten years, Z...aring her progress and the secret behind her succe...se of her video diaries which include a direct com...t. , (PRWeb UK) November ... Siklosi has released the video diaries that docum...
(Date:11/23/2009)...FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ),aleading...thehealthcareandcommercialindustries,announcedtoda...SiemensHealthServices,hasjoinedInfoLogixasVicePres...ttp://www.newscom.com/cgi-bin/prnh/20090618/NE3513...ServicesforInfoLogix,Mr.Waywillberesponsibleforthe...
(Date:11/23/2009)...d survivors treated with chemotherapy suffer insom...onditions, hindering patients, ability to fully re...f Rochester Medical Center. , A study of 823 can...s at nearly three times the rate of the general po...r patients and those with lung and breast cancers,...
Breaking Medicine News(10 mins):Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2
... a direct link between a human gene and the risk o...am led by Professor Marco Polo from the National C...at genetically engineered mice with a mutation in ...Proceedings of the National Academy of Cancers.// ...
...table genes to enable people to produce more ‘perf... to family relationships and on being human, warns...ring parents with inheritable diseases hold out gr... children.// However, the report warns that I...
..., the heart can actually repair itself by growing ...scovery was uncovered by researchers in New York a...New York Medical College in Valhalla detected sign...died within a few days of having a heart attack an...
...iglets last week could significantly increase the ..., according to creators, PPL Therapeutics. Previo... cells and organs by the human immune system is pa..., flagging them up as foreign bodies. A US su...
...g techniques, scientists have indicated the patter...mories are going to be stored or deleted. The stud...ute of Technology (MIT) and reported to the Americ...the very complex process of creating and storing m...
...Americans will probably have to depend on current ...al attack this year Second-generation vaccines are...roved anthrax vaccine that's ready to go, approved...tory repeatedly failed FDA inspections.``This is t...
Other Medicine News:Health News:Perfect babies boon or a bane? 2Health News:Xenotransplantation “breakthrough” 2
(Date:11/23/2009)...e-FirstCall/--BostonScientificCorporation(NYSE: BS...CareConference,December1-2. ,, RayElliott,Presi...cePresidentandChiefFinancialOfficer,willparticipat...cember1st,beginningatapproximately9:00a.m.E.T. ,...linterestedpartiesatBostonScientific,swebsiteat ww...
(Date:11/23/2009)...swire-FirstCall/--DURECTCorporation(Nasdaq: DRRX )...andJoeStauffer,ChiefMedicalOfficer,willbepresentin...Tuesday,December1at3:30pmEasternTime.Theconference..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...nviatheinternet,pleasegotothedirectconferencelinka...
(Date:11/23/2009)...eportlinker.comannouncesthatanewmarketresearchrepo...DiagnosticImagingMarketto2015 ,, http://www....stic-Imaging-Market-to-2015.html#utm_source=prnews... ,, Description ,, TheFutureoftheDiagn...balMarketsDirect,s"TheFutureoftheDiagnosticImaging...
Breaking Medicine Technology:DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 2Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 3Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 4Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 5Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 6Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 7Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 8Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 9Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 10Reportlinker Adds The Future of the Diagnostic Imaging Market to 2015 11Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 1Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211 a Novel Product Candidate for the Treatment of Respiratory Diseases 50392 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 1Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 2Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 3Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 4Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products 50389 5Huge Potential Returns for Healthcare Innovators 50385 1
...za Conference, HIGH WYCOMBE, England, June 18, 200...cal data showing how a new flu vaccine has the,pot..., including,pandemic and annual, was presented tod...l of Influenza VI (Options) Conference, in,Toronto...e published in the,European Journal of Immunology,...
...ved at 8 am versus placebo: - 25,/ - 13 mm Hg (sys...ependent on vaccine dose and induced,antiangiotens...d today at the Seventeenth European,Meeting on Hyp...witzerland and MILAN, Italy, June 17, 2007 -,Cytos...linical data,on its hypertension vaccine CYT006-An...
Other Medicine Technology:New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 2New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 3New Flu Vaccine From PepTcell Could Provide Immunity Against All,Strains of Influenza Virus 4Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 2Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 3Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 4Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 5Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 6Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 7Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 8Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur 9
The Natural-Hip Family - Revision/Trauma Nonporous CoCr
MARATHON Cross Linked Polyethylene Acetabular Liner
Ringloc Acetabular Liners
Olympia Total Shoulder System
Medicine Products: